RecruitingPhase 4NCT06333145
ED90 of Remimazolam Anesthesia Induction in Drug-induced Sleep Endoscopy in Adults
The 90% Effective Dose (ED90) of Remimazolam Anesthesia Induction in Drug-induced Sleep Endoscope in Adult: an up and Down Sequential Trial
Sponsor
Tongji Hospital
Enrollment
165 participants
Start Date
Feb 4, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Exploring the ED90 of remimazolam in Drug-induced Sleep Endoscopy in adults at different BMI groups.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria1
- \. Age 18-65 years old, 2. ASA Ⅰ-Ⅲ level; 3. Sign an informed consent form.
Exclusion Criteria1
- A history of central nervous system diseases, cognitive disorders, mental disorders, or communication disorders; 2.serious cardiovascular, respiratory, liver or kidney disease; 3.Anticipated need for tracheal intubation or laryngeal mask; 4.Allergic to benzodiazepines and opioids; 5.Those who have taken sedative, analgesic or antidepressant drugs within 24 hours; 6.Abnormal liver and kidney function; 7.Recently participated in other clinical studies.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGRemimazolam
Exploring ED90 induced by remimazolam anesthesia in adults of different BMI groups undergoing drug-induced sleep endoscopy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06333145
Related Trials
Effects of Salbutamol in Athletes and Implications for Screening and Sports
NCT070375111 location
Sedation Efficacy and Safety of Remazolam Besylate in Ventilated Surgical Critically Ill Patients
NCT065755301 location
Compare the Efficacy and Outcome Between Fentanyl and Morphine as Analgo-sedation in Mechanically Ventilated Patients
NCT064796551 location
Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder
NCT064797201 location
Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity
NCT059688851 location